NCT06664281

Brief Summary

Comparison of the effects of combined Sprint Interval Training (SIT) with Remote Ischemic Preconditioning (RIPC) and SIT on vascular function in young women with masked obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 24, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 29, 2024

Completed
Last Updated

October 29, 2024

Status Verified

September 1, 2024

Enrollment Period

8 months

First QC Date

October 24, 2024

Last Update Submit

October 28, 2024

Conditions

Keywords

Sprint Interval TrainingMasked ObesityYoung WomenIschemic PreconditioningVascular Function

Outcome Measures

Primary Outcomes (2)

  • Intima-Media Thickness (IMT)

    Changes in Intima media thickness before and after intervention.

    8 weeks

  • Flow-Mediated Dilation (FMD)

    Changes in Flow-mediated dilation before and after Intervention. Brachial artery flow-mediated dilation (FMD) was measured by the UNEXEF high-resolution ultrasound vascular endothelial function analyzer.

    8 weeks

Secondary Outcomes (5)

  • Body Composition Indicator

    8 weeks

  • Human Morphometric i Indicators

    8 weeks

  • Blood Pressure (BP)

    8 weeks

  • Nitric Oxide (NO)

    8 weeks

  • Maximum Oxygen Uptake (VO2max)

    8 weeks

Study Arms (3)

sprint interval training group

ACTIVE COMPARATOR
Behavioral: SIT

sprint interval training combined with remote ischemic preconditioning group

ACTIVE COMPARATOR
Behavioral: SIT combined RIPC

Control group

NO INTERVENTION

Interventions

SITBEHAVIORAL

sprint interval training

sprint interval training group

sprint interval training combined with remote ischemic preconditioning

sprint interval training combined with remote ischemic preconditioning group

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Females aged between 18 and 30 years;
  • BMI within the normal range (18.5~24.9 kg/m²), BF% \> 30%;
  • Participants with no clinically diagnosed contraindications for exercise, in good health, and not engaged in regular exercise, as determined by the health and physical activity questionnaire (based on the American College of Sports Medicine's guidelines for exercise testing and prescription).

You may not qualify if:

  • History of cardiovascular diseases, including coronary heart disease, stroke, or peripheral arterial disease diagnosed through vascular imaging techniques;
  • Currently participating in other intervention studies, including dietary, nutritional, or psychological education programs;
  • Those with regular professional training;
  • Musculoskeletal disorders that make long-term exercise interventions unsuitable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Sports Medicine and Rehabilitation, Beijing Sport University

Beijing, China

Location

Related Publications (1)

  • Ji Y, Yang L, Zhang P. Effects of sprint interval training combined with remote ischaemic preconditioning on vascular function in young women with masked obesity. Eur J Appl Physiol. 2025 Sep 22. doi: 10.1007/s00421-025-05970-4. Online ahead of print.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2024

First Posted

October 29, 2024

Study Start

February 28, 2023

Primary Completion

October 30, 2023

Study Completion

December 30, 2023

Last Updated

October 29, 2024

Record last verified: 2024-09

Locations